Padynex (Trastuzumab Emtansine) Lyophilized powder for reconstitution (100mg/vial and 160 mg/vial)

Padynex is an antibody-drug conjugate combining trastuzumab and a cytotoxic agent, DM1. It is used to target HER2-positive cancer cells specifically.